Active, not recruitingNot applicableNCT05791591
Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients
Studying Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- LGD
- Principal Investigator
- Matthias Canault, PhDLGD
- Intervention
- NUV001 - IR(dietary_supplement)
- Enrollment
- 168 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2023 – 2024
Study locations (8)
- Aman Hospital and Research Center, Vadodara, Gujarat, India
- Kingsway Hospital, Nagpur, Maharashtra, India
- Sai Krupa Hospital & Research Centre, Ahmedabad, India
- Thalassemia & Sickle Cell Society, Hyderabad, India
- Index Medical College, Indore, India
- NRSMC Hospital, Kolkata, India
- Arihant Hospital, Nagpur, India
- Shalinitai Meghe Hospital & Research Centre, Nagpur, India
Collaborators
ProRelix Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05791591 on ClinicalTrials.govOther trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07217548Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease PatientsOhio State University
- RECRUITINGPHASE2NCT07236190Biomarker-based Trial of NPC-1 for Alzheimer's PathologyMassachusetts General Hospital
- RECRUITINGPHASE1NCT06911008MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid CancersMayo Clinic
- ENROLLING BY INVITATIONNCT07331831Research on Attitudes, Confidence, and Practical Skills in Performing Cardiopulmonary Resuscitation and Automated External Defibrillation After Completing a Course Based on the European Resuscitation Council ModelFirst Three Minutes Foundation
- RECRUITINGNANCT07084142Developing a Digital Aid to Improve ICD DecisionsStanford University
- RECRUITINGNANCT06896825Increasing Physical Activity Through Social Support and Stress ResilienceArizona State University
- RECRUITINGNANCT07563660FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))Istanbul University - Cerrahpasa
- RECRUITINGPHASE1NCT06506461Gene Editing For Sickle Cell DiseaseSt. Jude Children's Research Hospital
See all trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome →